More MS patients who survived were currently on DMTs in comparison with those who died, but the difference did not reach statistical significance.
← all excerpts
INCREASED SEVERE COVID-19-RELATED FATALITY IN HOSPITALIZED MULTIPLE SCLEROSIS PATIENTS.
1
—
—